Buenor D. Puplampu, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 180 Grand Ave Ste 100, Oakland, CA 94612 Phone: 510-208-4700 Fax: 510-208-4540 |
Michael Alan Sheinberg, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 747 52nd St, Oakland, CA 94609 Phone: 510-428-3000 Fax: 510-450-5836 |
John G. Zovickian, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 275 W Macarthur, Oakland, CA 94611 Phone: 510-752-1000 |
Dachling Pang, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 275 W Macarthur, Oakland, CA 94611 Phone: 510-752-1000 |
Atul K Patel, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1411 E 31st St, Oakland, CA 94602 Phone: 510-437-4289 |
Kurtis Ian Auguste, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 744 52nd Street, Suite 5203, Oakland, CA 94609 Phone: 510-428-3319 Fax: 510-597-7034 |
Peter P. Sun, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 744 52nd St, 5th Floor, Oakland, CA 94609 Phone: 510-428-3319 Fax: 510-597-7034 |
News Archive
Medical researchers at the University of New South Wales (UNSW) - Australia, have shed light on a little-known mechanism involved in the thickening of arteries, a process associated with heart disease.
Ariel Pablos-Mendez, USAID assistant administrator for global health, writes in USAID's "IMPACTblog," "Recently, we reorganized the Global Health Bureau to establish an Office of Health Systems, which will be the hub for the Agency's worldwide leadership network of technical experts in health systems strengthening."
Ariosa Diagnostics (formerly Aria Diagnostics), a molecular diagnostics company, today announced the completion of its clinical validation study for the Harmony Prenatal Test.
The Florida Society of Pain Management Providers commends the Florida Board of Medicine and the Florida Board of Osteopathic Medicine in their issuances of Pain Clinic regulations / Standards of Care.
Researchers from Israel recently isolated a set of SARS-CoV-2 neutralizing monoclonal antibodies from blood samples of patients with severe COVID-19. They were the first to show that transgenic K18-hACE2 mice infected with lethal doses of SARS-CoV-2 can be fully protected by administering antibodies even 3 days after infection
› Verified 5 days ago